BioAdvance News Immunome Portfolio News

Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board

By WebmasterFebruary 8, 2023November 1st, 2024No Comments

Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board

Advisory board to help guide selection of novel antibody-target pairs for ADC and T cell redirection modalities

Previous PostPalvella Therapeutics Announces Pipeline Update on QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ Rapamycin) for Serious, Rare Genetic Skin Diseases with No FDA-approved Therapies
Next PostAnnovis Bio Announces Approval for European Union Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease